Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clare L Scott

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
The Lancet. Oncology|June 3, 2014
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialJonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
Blood|August 23, 2013
Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in miceOphélie Meynet, Barbara Zunino, Lina Happo, et al.
Cancers|April 23, 2022
Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian CancerJixuan Gao, MoonSun Jung, Rebekka T Williams, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapyAngelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
Iscience|July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancerHaineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcomaAndrew Farrell, Genevieve Dall, Cassandra J Vandenberg, et al.
Blood|June 13, 2012
E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesisKamil Wolyniec, Jake Shortt, Elisa de Stanchina, et al.
International Journal of Cancer|April 12, 2020
ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancerMoonsun Jung, Jixuan Gao, Leanna Cheung, et al.
Molecular Oncology|February 25, 2014
Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenograftsMonique D Topp, Lynne Hartley, Michele Cook, et al.
Cancers|September 9, 2023
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature ReviewArwa Abdelmogod, Lia Papadopoulos, Stephen Riordan, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
The Lancet. Oncology|June 3, 2014
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trialJonathan Ledermann, Philipp Harter, Charlie Gourley, et al.
Blood|August 23, 2013
Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in miceOphélie Meynet, Barbara Zunino, Lina Happo, et al.
Cancers|April 23, 2022
Suppression of the ABCA1 Cholesterol Transporter Impairs the Growth and Migration of Epithelial Ovarian CancerJixuan Gao, MoonSun Jung, Rebekka T Williams, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2021
Prognostic nomogram for progression-free survival in patients with BRCA mutations and platinum-sensitive recurrent ovarian cancer on maintenance olaparib therapy following response to chemotherapyAngelina Tjokrowidjaja, Michael Friedlander, Sarah J Lord, et al.
Iscience|July 18, 2024
CHK1 inhibitor SRA737 is active in PARP inhibitor resistant and <i>CCNE1</i> amplified ovarian cancerHaineng Xu, Sarah B Gitto, Gwo-Yaw Ho, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 6, 2026
High-throughput drug screening identifies EGFR/MAPK pathway targeting sensitivities in organoid models of ovarian carcinosarcomaAndrew Farrell, Genevieve Dall, Cassandra J Vandenberg, et al.
Blood|June 13, 2012
E6AP ubiquitin ligase regulates PML-induced senescence in Myc-driven lymphomagenesisKamil Wolyniec, Jake Shortt, Elisa de Stanchina, et al.
International Journal of Cancer|April 12, 2020
ABCC4/MRP4 contributes to the aggressiveness of Myc-associated epithelial ovarian cancerMoonsun Jung, Jixuan Gao, Leanna Cheung, et al.
Molecular Oncology|February 25, 2014
Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenograftsMonique D Topp, Lynne Hartley, Michele Cook, et al.
Cancers|September 9, 2023
A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature ReviewArwa Abdelmogod, Lia Papadopoulos, Stephen Riordan, et al.
Pageof 11